Columbia Asset Management Gsk PLC Transaction History

Columbia Asset Management

$493 Million
Q1 2024

A detailed history of Columbia Asset Management transactions in Gsk PLC stock. As of the latest transaction made, Columbia Asset Management holds 8,330 shares of GSK stock, worth $321,538. This represents 0.06% of its overall portfolio holdings.

Number of Shares

8,330

Previous 8,330 -0.0%

Holding current value

$321,538

Previous $309,000 -0.0%

% of portfolio

0.06%

Previous 0.06%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	SELL	$34.17 - $37.56 $55,697 - $61,222	-1,630 Reduced 16.37%	8,330 $309,000
Q3 2023 Nov 13, 2023	BUY	$33.81 - $38.07 $10,143 - $11,421	300 Added 3.11%	9,960 $361,000
Q2 2023 Aug 14, 2023	BUY	$33.6 - $38.32 $12,096 - $13,795	360 Added 3.87%	9,660 $344,000
Q1 2023 May 15, 2023	BUY	$33.5 - $36.43 $54,437 - $59,198	1,625 Added 21.17%	9,300 $331,000
Q4 2022 Feb 10, 2023	BUY	$30.0 - $37.92 $70,050 - $88,543	2,335 Added 43.73%	7,675 $270,000

Q3 2022 Nov 03, 2022	SELL	$16.13 - $44.61 $37,599 - $103,985	-2,331 Reduced 30.39%	5,340 $157,000
Q2 2022 Aug 26, 2022	SELL	$42.05 - $47.77 $87,926 - $99,887	-2,091 Reduced 21.42%	7,671 $334,000
Q4 2021 Feb 14, 2022	SELL	$38.88 - $45.31 $33,009 - $38,468	-849 Reduced 8.0%	9,762 $430,000
Q3 2021 Nov 15, 2021	SELL	$38.79 - $43.16 $11,055 - $12,300	-285 Reduced 2.62%	10,611 $405,000
Q2 2021 Aug 02, 2021	SELL	$36.52 - $41.46 $69,461 - $78,856	-1,902 Reduced 14.86%	10,896 $434,000
Q1 2021 May 28, 2021	SELL	$34.27 - $40.01 $117,134 - $136,754	-3,418 Reduced 21.08%	12,798 $457,000
Q4 2020 Feb 11, 2021	BUY	$34.07 - $39.94 $19,522 - $22,885	573 Added 3.66%	16,216 $597,000
Q3 2020 Nov 16, 2020	SELL	$38.11 - $42.99 $27,553 - $31,081	-723 Reduced 4.42%	15,643 $589,000
Q2 2020 Aug 14, 2020	BUY	$37.87 - $43.58 $78,580 - $90,428	2,075 Added 14.52%	16,366 $668,000
Q1 2020 May 14, 2020	SELL	$32.47 - $48.83 $31,658 - $47,609	-975 Reduced 6.39%	14,291 $542,000
Q3 2019 Nov 12, 2019	BUY	$40.46 - $43.52 $242 - $261	6 Added 0.04%	15,266 $652,000
Q2 2019 Aug 15, 2019	SELL	$39.4 - $42.7 $92,590 - $100,345	-2,350 Reduced 13.34%	15,260 $611,000
Q1 2019 May 20, 2019	BUY	$38.57 - $42.69 $91,796 - $101,602	2,380 Added 15.63%	17,610 $736,000
Q4 2018 Feb 12, 2019	BUY	$37.8 - $42.69 $3,779 - $4,269	100 Added 0.66%	15,230 $582,000
Q3 2018 Nov 06, 2018	SELL	$39.75 - $42.69 $49,687 - $53,362	-1,250 Reduced 7.63%	15,130 $608,000
Q1 2018 May 07, 2018	BUY	$36.18 - $40.15 $27,135 - $30,112	750 Added 4.8%	16,380 $640,000
Q4 2017 Feb 05, 2018	SELL	$35.34 - $41.9 $223,878 - $265,436	-6,335 Reduced 28.84%	15,630 $554,000
Q3 2017 Nov 07, 2017	BUY	$39.44 - $41.55 $866,299 - $912,645	21,965	21,965 $892,000

Others Institutions Holding GSK

# of Institutions

Shares Held

175K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $78.5B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Columbia Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Columbia Asset Management with notifications on news.

Account

Columbia Asset Management Gsk PLC Transaction History